Search

Search Results
Results 7231 - 7240 of 8359 for allergy
  • Lorazepam Viatris
    Drug - 9 Oct 2024
    Consumer Medicine Information (CMI) about Lorazepam Viatris (lorazepam) intended for persons living in Australia.
  • Increasing cases of mosquito-borne diseases call for greater awareness
    News - 8 Oct 2024
    The hospitalization last summer of Dr. Anthony Fauci, former head of the National Institute of Allergy and Infectious Diseases, with West Nile virus – and his account of it this week in the New York...
  • Tobramycin Viatris
    Drug - 20 Sep 2024
    Consumer Medicine Information (CMI) about Tobramycin Viatris (tobramycin) intended for persons living in Australia.
  • Octreotide Depot
    Drug - 6 Sep 2024
    Consumer Medicine Information (CMI) about Octreotide Depot (Octreotide) intended for persons living in Australia.
  • DBL Vinblastine
    Drug - 23 Aug 2024
    Consumer Medicine Information (CMI) about DBL Vinblastine (Vinblastine Sulfate) intended for persons living in Australia.
  • Hydopa
    Drug - 20 Aug 2024
    Consumer Medicine Information (CMI) about Hydopa (methyldopa) intended for persons living in Australia.
  • Pacrolim
    Drug - 12 Aug 2024
    Consumer Medicine Information (CMI) about Pacrolim (Tacrolimus) intended for persons living in Australia.
  • Alphapress
    Drug - 29 Jul 2024
    Consumer Medicine Information (CMI) about Alphapress (hydralazine hydrochloride) intended for persons living in Australia.
  • Trajenta
    Drug - 1 Jul 2024
    Consumer Medicine Information (CMI) about Trajenta (linagliptin) intended for persons living in Australia.
  • Tazopip
    Drug - 27 Jun 2024
    Consumer Medicine Information (CMI) about Tazopip (Piperacillin and Tazobactam powder for injection) intended for persons living in Australia.

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback